INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 20.88 Million USD | 409.0% |
| 2022 | 4.1 Million USD | -60.79% |
| 2021 | 10.46 Million USD | -4.39% |
| 2020 | 10.94 Million USD | 509.72% |
| 2019 | 1.79 Million USD | 130.98% |
| 2018 | 777.34 Thousand USD | 191.78% |
| 2017 | 266.41 Thousand USD | -6.92% |
| 2016 | 286.22 Thousand USD | -50.63% |
| 2015 | 579.78 Thousand USD | 436.59% |
| 2014 | 108.05 Thousand USD | -11.83% |
| 2013 | 122.54 Thousand USD | -2.18% |
| 2012 | 125.26 Thousand USD | -2.04% |
| 2011 | 127.87 Thousand USD | -29.35% |
| 2010 | 180.99 Thousand USD | -37.12% |
| 2009 | 287.83 Thousand USD | -7.61% |
| 2008 | 311.55 Thousand USD | 939.14% |
| 2007 | 29.98 Thousand USD | -20.66% |
| 2006 | 37.78 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 18.03 Million USD | -1.56% |
| 2024 Q1 | 18.31 Million USD | -12.3% |
| 2023 FY | 20.88 Million USD | 409.0% |
| 2023 Q3 | 19.47 Million USD | 193.36% |
| 2023 Q4 | 20.88 Million USD | 7.25% |
| 2023 Q2 | 6.63 Million USD | 7.93% |
| 2023 Q1 | 6.15 Million USD | 49.89% |
| 2022 Q3 | 4.67 Million USD | -27.18% |
| 2022 Q4 | 4.1 Million USD | -12.28% |
| 2022 FY | 4.1 Million USD | -60.79% |
| 2022 Q1 | 8.52 Million USD | -18.59% |
| 2022 Q2 | 6.42 Million USD | -24.59% |
| 2021 Q1 | 10.19 Million USD | -6.92% |
| 2021 Q2 | 9.93 Million USD | -2.54% |
| 2021 FY | 10.46 Million USD | -4.39% |
| 2021 Q4 | 10.46 Million USD | 28.49% |
| 2021 Q3 | 8.14 Million USD | -17.98% |
| 2020 Q1 | 957.88 Thousand USD | -46.65% |
| 2020 FY | 10.94 Million USD | 509.72% |
| 2020 Q3 | 1.68 Million USD | -26.75% |
| 2020 Q2 | 2.3 Million USD | 140.71% |
| 2020 Q4 | 10.94 Million USD | 548.16% |
| 2019 Q2 | 3.39 Million USD | -3.07% |
| 2019 Q3 | 2.56 Million USD | -24.47% |
| 2019 FY | 1.79 Million USD | 130.98% |
| 2019 Q4 | 1.79 Million USD | -30.0% |
| 2019 Q1 | 3.5 Million USD | 350.67% |
| 2018 Q1 | 307.67 Thousand USD | 15.49% |
| 2018 FY | 777.34 Thousand USD | 191.78% |
| 2018 Q4 | 777.34 Thousand USD | -15.5% |
| 2018 Q3 | 919.99 Thousand USD | -19.53% |
| 2018 Q2 | 1.14 Million USD | 271.58% |
| 2017 Q1 | 194.49 Thousand USD | -32.05% |
| 2017 Q3 | 200.43 Thousand USD | 10.26% |
| 2017 Q2 | 181.78 Thousand USD | -6.54% |
| 2017 Q4 | 266.41 Thousand USD | 32.92% |
| 2017 FY | 266.41 Thousand USD | -6.92% |
| 2016 FY | 286.22 Thousand USD | -50.63% |
| 2016 Q3 | 389.51 Thousand USD | -14.39% |
| 2016 Q1 | 549.27 Thousand USD | -5.26% |
| 2016 Q2 | 455 Thousand USD | -17.16% |
| 2016 Q4 | 286.22 Thousand USD | -26.52% |
| 2015 FY | 579.78 Thousand USD | 436.59% |
| 2015 Q4 | 579.78 Thousand USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | 108.05 Thousand USD | -11.83% |
| 2013 FY | 122.54 Thousand USD | -2.18% |
| 2012 FY | 125.26 Thousand USD | -2.04% |
| 2011 Q3 | 134.58 Thousand USD | -11.69% |
| 2011 Q1 | 165.13 Thousand USD | -8.76% |
| 2011 Q4 | 127.87 Thousand USD | -4.99% |
| 2011 Q2 | 152.4 Thousand USD | -7.71% |
| 2011 FY | 127.87 Thousand USD | -29.35% |
| 2010 Q4 | 180.99 Thousand USD | 2.19% |
| 2010 Q3 | 177.11 Thousand USD | -8.05% |
| 2010 Q2 | 192.62 Thousand USD | -2.33% |
| 2010 Q1 | 197.21 Thousand USD | -31.48% |
| 2010 FY | 180.99 Thousand USD | -37.12% |
| 2009 FY | 287.83 Thousand USD | -7.61% |
| 2009 Q4 | 287.83 Thousand USD | -34.31% |
| 2009 Q1 | 303.33 Thousand USD | -2.64% |
| 2009 Q3 | 438.19 Thousand USD | 62.99% |
| 2009 Q2 | 268.85 Thousand USD | -11.37% |
| 2008 Q2 | 13.16 Thousand USD | -32.66% |
| 2008 Q1 | 19.55 Thousand USD | -34.79% |
| 2008 Q4 | 311.55 Thousand USD | 4499.96% |
| 2008 Q3 | 6773.00 USD | -48.56% |
| 2008 FY | 311.55 Thousand USD | 939.14% |
| 2007 FY | 29.98 Thousand USD | -20.66% |
| 2007 Q4 | 29.98 Thousand USD | 0.0% |
| 2006 FY | 37.78 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 33.406% |
| BrainsWay Ltd. | 62.97 Million USD | 66.83% |
| Cerus Corporation | 197.74 Million USD | 89.437% |
| Envoy Medical, Inc. | 7.64 Million USD | -173.4% |
| electroCore, Inc. | 16.38 Million USD | -27.466% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -171.552% |
| IceCure Medical Ltd | 16.41 Million USD | -27.287% |
| Inogen, Inc. | 326.19 Million USD | 93.597% |
| OrthoPediatrics Corp. | 449.58 Million USD | 95.354% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 23.404% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -25.989% |
| MaxCyte, Inc. | 268.27 Million USD | 92.214% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -157.959% |
| Nexalin Technology, Inc. | 3.63 Million USD | -475.118% |
| Orthofix Medical Inc. | 925.31 Million USD | 97.743% |
| PAVmed Inc | 33.11 Million USD | 36.931% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 85.439% |
| RxSight, Inc. | 182.55 Million USD | 88.558% |
| Sight Sciences, Inc. | 166.65 Million USD | 87.466% |
| SI-BONE, Inc. | 230.42 Million USD | 90.935% |
| TELA Bio, Inc. | 78.04 Million USD | 73.237% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 91.708% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -94.667% |
| Acutus Medical, Inc. | 53.96 Million USD | 61.29% |
| Talis Biomedical Corporation | 98.34 Million USD | 78.76% |
| Spectral AI, Inc. | 10.69 Million USD | -95.359% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 90.447% |
| CVRx, Inc. | 115.22 Million USD | 81.873% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 64.392% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -570.501% |
| Bioventus Inc. | 810.91 Million USD | 97.424% |
| Venus Concept Inc. | 93.65 Million USD | 77.697% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 18.804% |
| LivaNova PLC | 2.42 Billion USD | 99.14% |
| 908 Devices Inc. | 202.98 Million USD | 89.709% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 97.406% |
| Nemaura Medical Inc. | 14.56 Million USD | -43.428% |
| NeuroPace, Inc. | 107.65 Million USD | 80.597% |
| LENSAR, Inc. | 69.58 Million USD | 69.982% |
| Apyx Medical Corporation | 79.24 Million USD | 73.64% |
| Cutera, Inc. | 346.29 Million USD | 93.968% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 50.286% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1061.723% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 92.282% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 51.038% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.448% |
| Axonics, Inc. | 719.92 Million USD | 97.099% |
| Outset Medical, Inc. | 313.8 Million USD | 93.344% |
| IRIDEX Corporation | 34.43 Million USD | 39.343% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 94.839% |
| IRadimed Corporation | 92.15 Million USD | 77.334% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -297.56% |
| Telesis Bio, Inc. | 70.41 Million USD | 70.334% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 86.446% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.328% |
| Quipt Home Medical Corp. | 247.4 Million USD | 91.557% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -124.359% |
| Pulmonx Corporation | 178.95 Million USD | 88.328% |
| Dynatronics Corporation | 25.94 Million USD | 19.478% |
| Modular Medical, Inc. | 13.8 Million USD | -51.284% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -94.722% |
| Semler Scientific, Inc. | 78.06 Million USD | 73.243% |
| InMode Ltd. | 863.28 Million USD | 97.58% |
| Bruker Corporation | 4.24 Billion USD | 99.509% |
| Cytosorbents Corporation | 53.26 Million USD | 60.782% |
| DexCom, Inc. | 6.26 Billion USD | 99.667% |
| Align Technology, Inc. | 6.08 Billion USD | 99.657% |
| Viveve Medical, Inc. | 25.91 Million USD | 19.393% |
| ZimVie Inc. | 1.2 Billion USD | 98.267% |
| Movano Inc. | 9.42 Million USD | -121.715% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 95.803% |
| Nexalin Technology, Inc. | 3.63 Million USD | -475.118% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 64.392% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 97.807% |
| Profound Medical Corp. | 43.68 Million USD | 52.187% |
| Insulet Corporation | 2.58 Billion USD | 99.193% |
| enVVeno Medical Corporation | 48.63 Million USD | 57.052% |
| Surmodics, Inc. | 185.73 Million USD | 88.754% |
| iCAD, Inc. | 41.41 Million USD | 49.568% |
| Nuwellis, Inc. | 9.77 Million USD | -113.795% |
| Biotricity, Inc. | 5.94 Million USD | -251.491% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 95.178% |
| Aethlon Medical, Inc. | 8.24 Million USD | -153.309% |
| InspireMD, Inc. | 47.64 Million USD | 56.158% |
| PAVmed Inc. | 33.11 Million USD | 36.931% |
| BIOLASE, Inc. | 35.1 Million USD | 40.492% |
| Beyond Air, Inc. | 56.96 Million USD | 63.33% |
| FONAR Corporation | 214.24 Million USD | 90.251% |
| AxoGen, Inc. | 196.82 Million USD | 89.388% |
| Vivani Medical, Inc. | 45.79 Million USD | 54.39% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 92.578% |
| Inari Medical, Inc. | 674.23 Million USD | 96.902% |
| UFP Technologies, Inc. | 404.13 Million USD | 94.831% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 10.73% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -119.799% |
| Tenon Medical, Inc. | 6.34 Million USD | -229.201% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -122.045% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 79.847% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.548% |
| Sintx Technologies, Inc. | 15.36 Million USD | -35.944% |
| NanoVibronix, Inc. | 6.67 Million USD | -212.973% |
| Quanterix Corporation | 425.01 Million USD | 95.085% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -124.359% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 61.122% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.804% |
| TransMedics Group, Inc. | 706.04 Million USD | 97.042% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 66.946% |
| NeuroMetrix, Inc. | 21.42 Million USD | 2.505% |
| Hyperfine, Inc. | 94.19 Million USD | 77.826% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 92.225% |
| Biomerica, Inc. | 9.25 Million USD | -125.716% |
| Bone Biologics Corporation | 3.73 Million USD | -458.831% |
| AVITA Medical, Inc. | 144.33 Million USD | 85.529% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -329.037% |
| Silk Road Medical, Inc | 265.3 Million USD | 92.127% |